ZNTL - Wall Street Estimates - Zentalis Pharmaceuticals, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 2.24

-6.28 %

$ 160 M

Market Cap

-0.9

P/E

Price Target Average

435.71%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

35.33%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Zentalis Pharmaceuticals, Inc.

Wall Street analysts predict an average 1-year price target for ZNTL of $12 , with forecasts ranging from a low of $4 to a high of $32 .

ZNTL Lowest Price Target Wall Street Target

4 USD 78.57%

ZNTL Average Price Target Wall Street Target

12 USD 435.71%

ZNTL Highest Price Target Wall Street Target

32 USD 1328.57%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free